Oncology Peer Review On-The-Go: Germline Testing in Prostate Cancer: When and Who to Test
The recent episode of the "Oncology Peer Review On-The-Go" podcast features Alexandra Sokolova, MD, discussing her article on germline testing and NCCN guidelines for patients with prostate cancer.
This week, CancerNetwork looks at an article from the October issue of the journal ONCOLOGY, titled “Germline Testing in Prostate Cancer: When and Who to Test.” CancerNetwork spoke with one of the authors of the article, Alexandra Sokolova, MD, an assistant professor at Oregon Health & Science University. CancerNetwork and Sokolova discussed the treatment implications of germline testing and how this type of testing is becoming more commonplace.
Sokolova detailed the article, which summarizes germline testing recommendations for prostate cancer, including the recently updated National Comprehensive Cancer Network guidelines. She also described care models for providing counsel and testing for patients with prostate cancer.
Don’t forget to subscribe to the "Oncology Peer Review On-The-Go" podcast on Apple Podcasts, Spotify, or anywhere podcasts are available.
Prolaris in Practice: Guiding ADT Benefits, Clinical Application, and Expert Insights From ACRO 2025
April 15th 2025Steven E. Finkelstein, MD, DABR, FACRO discuses how Prolaris distinguishes itself from other genomic biomarker platforms by providing uniquely actionable clinical information that quantifies the absolute benefit of androgen deprivation therapy when added to radiation therapy, offering clinicians a more precise tool for personalizing prostate cancer treatment strategies.
